Detalhe da pesquisa
1.
Quantum Mechanical Assessment of Nitrosamine Potency.
Chem Res Toxicol
; 2024 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38804898
2.
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs).
Regul Toxicol Pharmacol
; 142: 105415, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37257751
3.
An inherited night blindness in Wiltshire sheep.
Vet Pathol
; 59(2): 310-318, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34974772
4.
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids.
Regul Toxicol Pharmacol
; 134: 105242, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35964842
5.
Skin sensitization in silico protocol.
Regul Toxicol Pharmacol
; 116: 104688, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32621976
6.
A community effort for automatic detection of postictal generalized EEG suppression in epilepsy.
BMC Med Inform Decis Mak
; 20(Suppl 12): 328, 2020 12 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33357232
7.
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
Mutagenesis
; 34(1): 67-82, 2019 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30189015
8.
ß-Mannosidosis in German Shepherd Dogs.
Vet Pathol
; 56(5): 743-748, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30983534
9.
Genetic toxicology in silico protocol.
Regul Toxicol Pharmacol
; 107: 104403, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31195068
10.
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses.
Regul Toxicol Pharmacol
; 102: 53-64, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30562600
11.
In silico toxicology protocols.
Regul Toxicol Pharmacol
; 96: 1-17, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29678766
12.
Assessing Concordance of Drug-Induced Transcriptional Response in Rodent Liver and Cultured Hepatocytes.
PLoS Comput Biol
; 12(3): e1004847, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27028627
13.
Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA.
J Inherit Metab Dis
; 40(3): 443-453, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27832416
14.
It's difficult, but important, to make negative predictions.
Regul Toxicol Pharmacol
; 76: 79-86, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26785392
15.
Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning.
Regul Toxicol Pharmacol
; 79 Suppl 1: S19-27, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27233923
16.
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.
Regul Toxicol Pharmacol
; 79 Suppl 1: S39-47, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27267172
17.
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Regul Toxicol Pharmacol
; 77: 1-12, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26879463
18.
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Regul Toxicol Pharmacol
; 77: 13-24, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26877192
19.
Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain.
J Inherit Metab Dis
; 38(2): 341-50, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25421091
20.
An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.
Regul Toxicol Pharmacol
; 71(3): 388-97, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25656493